CS
Ligand Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Promacta/Revolade (eltrombopag) | Chronic ITP, Aplastic Anemia | Marketed |
| Kyprolis (carfilzomib) | Multiple Myeloma | Marketed |
| Veklury (remdesivir) | COVID-19 | Marketed |
| Vascepa (icosapent ethyl) | Cardiovascular Risk Reduction | Marketed |
| Jemperli (dostarlimab) | Endometrial Cancer | Marketed |
| VK2735 (Viking Partnership) | NASH, Obesity | Phase 2 |
| Ibrexafungerp (Scynexis Partnership) | Fungal Infections | Marketed |